… , and its role in metabolism and adipose tissue … that endocannabinoid system members
(endocannabinoid receptor-2, N-acyl phosphatidylethanolamine phospholipase D and fatty acid …

… In parallel, obese mice treated with rimonabant improved the lipid profile, which could be
just the result of the negative energy balance induced by the treatment [215]. On the other hand…

… tissues modulate eCB biosynthesis. Thus, our findings of increased 2-AG in liver and AEA in
visceral adipose tissue … liver and adipose tissue in the presence of altered lipid and glucose …

… CBD inhibits fatty acid amide hydrolase (FAAH) [43] and can … increase levels of
endocannabinoids and related lipids. They may … stress, endocannabinoid levels and lipid …

… The endocannabinoid system is … metabolism of the endocannabinoids, 2-arachidonoyl-sn-glycerol
and arachidonoyl ethanolamide, and related monoacylglycerols (MAGs) and fatty acid …

… system has been targeted in obesity due to associations with appetite control, energy
homoeostasis, lipid metabolism, and inflammation. Despite this, WAT of humans living with …

… in energy balance and lipid metabolism regulation, (33) and more recently it is found to
involve controlling lipid droplet fusion and lipid storage in brown and white adipose tissues. (34) …

… lipid ligands which are responsible for enhanced feeding behavior as well as lipid metabolism.
… the biological effect in adipose tissue with existence of endocannabinoids in white and …

… adipose tissue depots may be the major source of circulating endocannabinoids during the
consumption of high-fat diets … to liver lipid homeostasis, generally promoting lipid metabolism. …

… in liver, muscle, white adipose tissue (WAT) and brown adipose tissue (BAT) during the course
… activates adipose tissue depots to increase the synthesis pathways of endocannabinoids …